Overview

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this trial is to determine whether lacosamide is safe and effective for long-term use in patients with partial-seizures from epilepsy
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
UCB BIOSCIENCES, Inc.
Treatments:
Lacosamide
Criteria
Inclusion Criteria:

- Completion of parent clinical trial for treatment of partial seizures

Exclusion Criteria:

- Receiving any study drug or experimental device other than lacosamide

- Meets withdrawal criteria for parent trial or experiencing ongoing serious adverse
event